Aura Biosciences, Inc. AURA Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $84.79M+122% | $59.52M+87.8% | $47.55M+87.2% | $107.37M+257% | $38.23M+45.5% | ||
| $768K0.0% | $768K— | $768K— | $768K— | $768K— | ||
| $3.77M-42.2% | $5.5M-42.3% | $8.25M-9.3% | $6.65M-18.7% | $6.53M-30.4% | ||
| $118.5M-11.9% | $149.74M-6.8% | $170.12M-7.3% | $183.96M-6.0% | $134.52M-36.6% | ||
| $2.47M-20.5% | $2.62M-18.4% | $2.63M-20.9% | $2.86M-14.1% | $3.11M+1.9% | ||
| $15.42M-9.3% | $15.83M-8.9% | $16.23M-8.5% | $16.62M-8.4% | $17.01M-8.1% | ||
| $517K— | $471K-9.1% | $277K+1,159% | $185K-58.2% | $0-100% | ||
| $137.68M-11.4% | $169.43M-7.2% | $190.02M-7.5% | $204.4M-6.4% | $155.4M-33.9% | ||
| $7.3M-6.0% | $6.73M-12.5% | $7.48M+4.4% | $7.59M+13.8% | $7.76M+34.7% | ||
| $3.27M+3.0% | $3.24M+3.0% | $3.22M+3.0% | $3.2M+16.0% | $3.17M+15.7% | ||
| $16.71M+37.4% | $18.38M+23.3% | $18.82M+27.9% | $14.85M+40.8% | $12.16M+25.9% | ||
| $13.72M-10.1% | $14.13M-9.5% | $14.53M-8.9% | $14.92M-8.4% | $15.27M-7.9% | ||
| $16.99M-7.9% | $17.38M-7.4% | $17.75M-7.0% | $18.11M-4.8% | $18.44M-4.5% | ||
| $30.43M+10.9% | $32.52M+6.5% | $33.36M+8.8% | $29.77M+11.0% | $27.44M+4.5% | ||
| $621.56M+17.4% | $617.43M+17.4% | $611.46M+17.0% | $603.33M+16.3% | $529.57M+2.7% | ||
| -$514.1M-28.0% | -$480.42M-28.4% | -$454.86M-30.6% | -$428.73M-31.0% | -$401.71M-30.8% | ||
| -$207K-297% | -$102K-139% | $69K-88.6% | $25K+114% | $105K+483% | ||
| $107.25M-16.2% | $136.91M-9.9% | $156.67M-10.3% | $174.63M-8.8% | $127.97M-38.7% | ||
| $137.68M-11.4% | $169.43M-7.2% | $190.02M-7.5% | $204.4M-6.4% | $155.4M-33.9% | ||
| $517K— | $471K-9.1% | $277K+1,159% | $185K-58.2% | $0-100% | ||
| $15.42M-9.3% | $15.83M-8.9% | $16.23M-8.5% | $16.62M-8.4% | $17.01M-8.1% | ||
| $15.42M-9.3% | $15.83M-8.9% | $16.23M-8.5% | $16.62M-8.4% | $17.01M-8.1% | ||
| $517K— | $471K-9.1% | $277K+1,159% | $185K-58.2% | $0-100% | ||
| $15.42M-9.3% | $15.83M-8.9% | $16.23M-8.5% | $16.62M-8.4% | $17.01M-8.1% | ||
| $517K— | $471K-9.1% | $277K+1,159% | $185K-58.2% | $0-100% | ||
| $10.87M+55.6% | $13.59M+43.7% | $13.72M+42.9% | $10.37M+63.7% | $6.99M+40.0% | ||
| $16.99M-7.9% | $17.38M-7.4% | $17.75M-7.0% | $18.11M-4.8% | $18.44M-4.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Aura Biosciences, Inc.'s total assets?
- Aura Biosciences, Inc. (AURA) holds $137.7M in total assets, down 11.4% year over year.
- How much debt does Aura Biosciences, Inc. have?
- Aura Biosciences, Inc. carries $17.0M in total debt against $107.2M of shareholders' equity, a debt-to-equity ratio of 0.16.
- How much cash does Aura Biosciences, Inc. have?
- Aura Biosciences, Inc. holds $84.8M in cash and equivalents.
- Can Aura Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 7.09 — current assets exceed current liabilities.
- Where does Aura Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Aura Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.